EUVIMEDEUVIMED entdecken
Crossref

Rehabilitation of patients after CAR T-cell therapy. Experiences on 5 patients

Thomas Kiefer, Christian Lüders, Heinz Völler, Georg Daeschlein

Transplant Immunology · 2023-02 · 76 · 101770

DOI: 10.1016/j.trim.2022.101770 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Immunology, 2023-02. Verfasst von Thomas Kiefer und 3 weiteren Autor:innen. Beteiligte Einrichtung: Klinik am See, Rehabilitationszentrum, Rüdersdorf, Germany; Medical University Brandenburg "Theodor Fontane", Germany. Electronic address: Thomas.Kie…. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: CAR T-cell therapy is an effective treatment for various relapsed or refractory haemato-oncological diseases. However, this therapy results in significant immunosuppression that lasts for months. Whether these patients are at risk during a rehabilitation stay, e.g., due to infections, has not yet been answered. METHODS: We describe the rehabilitation stay under special hygienic conditions of the five patients rehabilitated in our clinic after CAR T-cell therapy. Complications that occurred during rehabilitation are reported, as well as the positive effects of rehabilitation on physical performance, polyneuropathic complaints, anxiety and depression, and individual limitations. RESULTS: One patient reported signs of infection already at the beginning of rehabilitation. This was treated with antibiotics, and rehabilitation could be continued. No complications occurred in any of the other patients. All patients reported having benefited physically and psychologically from the rehabilitation, and two expressed the intention to return to work. CONCLUSIONS: As far as we know, this is the first report on several patients after CAR T-cell therapy. Based on the limited data, there is no reason to withhold a rehabilitation stay from patients after CAR T-cell therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunotherapy, AdoptiveReceptors, Chimeric AntigenHumansAntigens, CD19Treatment Outcome

Stichwörter der Autor:innen

CAR T-cell therapyInfectionRehabilitationSafety

Substanzen

Receptors, Chimeric AntigenAntigens, CD19

Autor:innen und Institutionen

  • Klinik am See, Rehabilitationszentrum, Rüdersdorf, Germany; Medical University Brandenburg "Theodor Fontane", Germany. Electronic address: Thomas.Kiefer-Trendelenburg@klinikamsee.com.
  • Klinik am See, Rehabilitationszentrum, Rüdersdorf, Germany.
  • Klinik am See, Rehabilitationszentrum, Rüdersdorf, Germany; Universität Potsdam, Professur für Rehabilitationswissenschaften, humanwissenschaftliche Fakultät, Germany.
  • Clinic of Dermatology, Immunology and Allergology, Medical Center Dessau, Medical University Brandenburg "Theodor Fontane" Medical Center Dessau, Germany.

Zitieren

APA

Kiefer, T., Lüders, C., Völler, H., & Daeschlein, G. (2023). Rehabilitation of patients after CAR T-cell therapy. Experiences on 5 patients. Transplant Immunology, 76, 101770. https://doi.org/10.1016/j.trim.2022.101770

Vancouver

Kiefer T, Lüders C, Völler H, Daeschlein G. Rehabilitation of patients after CAR T-cell therapy. Experiences on 5 patients. Transplant Immunology. 2023;76:101770. doi:10.1016/j.trim.2022.101770

BibTeX
@article{Kiefer2023,
  author = {Kiefer, Thomas and Lüders, Christian and Völler, Heinz and Daeschlein, Georg},
  title = {Rehabilitation of patients after CAR T-cell therapy. Experiences on 5 patients},
  journal = {Transplant Immunology},
  year = {2023},
  volume = {76},
  pages = {101770},
  doi = {10.1016/j.trim.2022.101770}
}
Kostenlos starten →